Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Moodys
Dow
Teva
Chinese Patent Office
Harvard Business School
Cipla
McKinsey
Argus Health

Generated: May 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 208036

« Back to Dashboard

NDA 208036 describes E-Z-PAQUE, which is a drug marketed by Bracco and is included in one NDA. It is available from one supplier. Additional details are available on the E-Z-PAQUE profile page.

The generic ingredient in E-Z-PAQUE is barium sulfate. One supplier is listed for this compound. Additional details are available on the barium sulfate profile page.
Summary for 208036
Tradename:E-Z-PAQUE
Applicant:Bracco
Ingredient:barium sulfate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 208036
Mechanism of ActionX-Ray Contrast Activity
Medical Subject Heading (MeSH) Categories for 208036
Suppliers and Packaging for NDA: 208036
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
E-Z-CAT DRY barium sulfate FOR SUSPENSION;ORAL 208036 NDA E-Z-EM Canada Inc 32909-750 N 32909-750-03
E-Z-CAT DRY barium sulfate FOR SUSPENSION;ORAL 208036 NDA E-Z-EM Canada Inc 32909-764 N 32909-764-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:FOR SUSPENSION;ORALStrength98% (334GM/BOT)
Approval Date:Jan 11, 2016TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:FOR SUSPENSION;ORALStrength96% (169GM/BOT)
Approval Date:Apr 7, 2017TE:RLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:FOR SUSPENSION;ORALStrength40% (9GM/POUCH)
Approval Date:Jan 3, 2017TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Dow
Queensland Health
Fish and Richardson
Johnson and Johnson
Mallinckrodt
QuintilesIMS
Boehringer Ingelheim
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.